Amedisys Reports Fourth Quarter and Year End 2019 Financial Results and Issues 2020 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. ONON
6. AAPL
7. TRMD
8. AZN
9. BETR
10. DIS

Go back to Amedisys Reports Fourth Quarter and Year End 2019 Financial Results and Issues 2020 Guidance

Amedisys (AMED) Tops Q4 EPS by 1c, Revs Miss

February 18, 2020 4:17 PM EST

Amedisys (NASDAQ: AMED) reported Q4 EPS of $0.94, $0.01 better than the analyst estimate of $0.93. Revenue for the quarter came in at $500.7 million versus the consensus estimate of $511.55 million.

Paul B. Kusserow, Chairman, President and Chief Executive Officer stated, I am very proud... More